Hugo A. Katus
Expertise in
34
conditions

Hugo A. Katus

Heidelberg, BW, DE 
Expertise in
34
conditions
Heidelberg, BW, DE 

Overview

Hugo Katus practices practicing medicine in Heidelberg, Germany.

Mr. Katus is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Dilated Cardiomyopathy (DCM), Heart Failure, Heart Transplant, and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 709 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Heidelberg, BW 69120, Germany
Other Locations
Mannheim, BW, Germany
Kiel, SH, Germany
Berlin, BE 10785, Germany
Greifswald, MV 17475, Germany
Wuppertal, NW, Germany
Munich, BY, Germany
Germany
Hamburg, HH, Germany
Leipzig, SN, Germany
Hannover, NI, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
Enrollment Status: Completed
Publish Date: March 26, 2025
Intervention Type: Diagnostic test
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome - Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drugs: Ticagrelor, Prasugrel
Study Phase: Phase 4
Use of the Self-Expanding Medtronic CoreValve Prosthesis Without Predilation in Patients With Severely IMPaired Left-VentrIcular Ejection Fraction for TAVI Trial - The SIMPLIFy TAVI Trial
Use of the Self-Expanding Medtronic CoreValve Prosthesis Without Predilation in Patients With Severely IMPaired Left-VentrIcular Ejection Fraction for TAVI Trial - The SIMPLIFy TAVI Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload
A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload
Enrollment Status: Terminated
Publish Date: August 05, 2021
Intervention Type: Device
View 3 Less Clinical Trials

707 Total Publications

Fifth Universal Definition of Myocardial Infarction (2026): On Behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.
Fifth Universal Definition of Myocardial Infarction (2026): On Behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction.
Journal: Circulation
Published: August 28, 2026

Frequently Asked Questions about Hugo A. Katus

Is Hugo A. Katus a top-rated expert for Cardiomyopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Hugo A. Katus is classified as an Elite expert for Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hugo A. Katus participate in research or clinical trials?

Yes. Hugo A. Katus has published 707 articles and abstracts on conditions like Cardiomyopathy. You can view a list of Hugo A. Katus's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Katus's expertise for a condition
ConditionClose
View All 25 Advanced Conditions
View All 54 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile